In murine models, the administration of ghrelin during or after diet-induced NAFLD development counteracts dysregulated hepatic lipid metabolism, oxidative stress, apoptosis, and inflammation [35,36]. The gene discussed is GHRL; the disease is metabolic dysfunction-associated steatotic liver disease.